VASOGRADE简易分级量表预测动脉瘤性蛛网膜下腔出血后迟发性脑缺血与功能结局的作用
该研究回顾性评估2016年1月至2019年1月巴西一家高容量中心连续收治的212例动脉瘤性蛛网膜下腔出血患者,按WFNS、mFisher及VASOGRADE(绿、黄、红)分级。主要终点为迟发性脑缺血相关脑梗死,次要终点为出院时改良Rankin量表功能结局。VASOGRADE黄色和红色均独立关联迟发性脑缺血相关梗死(OR 7.69,95%CI 2.13-27.8;OR 8.07,95%CI 2.03-32.11)和不良结局(OR 4.16,95%CI 1.33-13.03;OR 25.57,95%CI 4.45-147.1)。VASOGRADE对迟发性脑缺血相关梗死的判别性能AUC为0.67±0.04(95%CI 0.58-0.75;p=0.001)。作者认为绿色患者可考虑早期转出ICU,黄色和红色患者应优先在高容量中心ICU积极监测迟发性脑缺血。
要点
- 212例aSAH中迟发性脑缺血相关梗死39例(18.9%);绿色、黄色、红色组分别为7.7%、61.5%、30.8%。
- 多因素分析校正年龄、性别、动脉瘤位置后,VASOGRADE黄色与迟发性脑缺血相关梗死独立相关(OR 7.69,95%CI 2.13-27.8),红色OR 8.07(95%CI 2.03-32.11)。
- VASOGRADE黄色与不良结局独立相关(OR 4.16,95%CI 1.33-13.03),红色OR 25.57(95%CI 4.45-147.1)。
- VASOGRADE红色预测出院不良mRs的特异度为97.5%(95%CI 92.8-99.5%);绿色预测出院良好结局(mRs 0-2)特异度95%CI 82.6-95.5%。
- VASOGRADE对迟发性脑缺血相关梗死的判别性能AUC 0.67±0.04(95%CI 0.58-0.75;p=0.001)。
适用人群与场景
- 2016年1月至2019年1月巴西一家高容量中心连续收治的212例动脉瘤性蛛网膜下腔出血患者,多民族队列,女性71.7%,平均年龄52.7±12.8岁。
诊断标准与关键阈值
- VASOGRADE分级结合改良Fisher量表(mFisher,初始头颅CT出血量)与WFNS分级(临床表现严重度),分为绿色、黄色、红色三级。
研究设计与关键结果
- 回顾性多民族队列研究,纳入巴西一家高容量中心2016年1月至2019年1月连续收治的212例aSAH患者。
- VASOGRADE绿色69例(32.5%)、黄色98例(46.9%)、红色45例(20.6%);迟发性脑缺血相关梗死共39例(18.9%),三组中分别占7.7%、61.5%、30.8%。
- 多因素分析(纳入年龄、性别、动脉瘤位置和VASOGRADE分类)显示,VASOGRADE黄色与迟发性脑缺血相关梗死独立相关(OR 7.69,95%CI 2.13-27.8),红色OR 8.07(95%CI 2.03-32.11);黄色与不良结局独立相关(OR 4.16,95%CI 1.33-13.03),红色OR 25.57(95%CI 4.45-147.1)。
- VASOGRADE对迟发性脑缺血相关梗死的判别性能AUC为0.67±0.04(95%CI 0.58-0.75;p=0.001)。
- VASOGRADE红色预测出院不良mRs评分的特异度为97.5%(95%CI 92.8-99.5%);VASOGRADE绿色预测出院良好结局(mRs评分0-2)特异度95%CI为82.6-95.5%。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,VASOGRADE绿色患者可考虑早期转出ICU,以减少费用及延长住院相关的医疗并发症。
- 作者认为,VASOGRADE黄色和红色患者迟发性脑缺血风险最高,应优先安排在高容量aSAH中心的ICU积极监测迟发性脑缺血。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The VASOGRADE is a simple aneurysmal subarachnoid hemorrhage (aSAH) grading scale that combines the modified Fisher scale (mFisher) and the World Federation of Neurological Societies (WFNS) grading system, allowing the stratification of delayed cerebral ischemia (DCI) risk. However, the VASOGRADE accuracy in predicting functional outcomes is still to be determined.
METHODS: We retrospectively evaluated a multiethnic cohort of consecutive patients with aSAH admitted to a high-volume center in Brazil from January 2016 to January 2019. Patients were classified according to the severity of the clinical presentation (WFNS), the amount of blood in the initial head computerized tomography (mFisher) scan, and the VASOGRADE (green, yellow, red). The primary outcome was to detect DCI-related cerebral infarction, and the secondary outcome was the functional outcome at hospital discharge according to the modified Rankin scale (mRs). Univariate and multivariate logistic regression models were employed.
RESULTS: A total of 212 patients (71.7% female, mean age 52.7 ± 12.8) were included. Sixty-nine patients were classified as VASOGRADE-Green (32.5%), 98 patients as VASOGRADE-Yellow (46.9%), and 45 patients as VASOGRADE-Red (20.6%). DCI-related infarction was present in 39 patients (18.9%). The proportions of patients in the VASOGRADE-Green, VASOGRADE-Yellow, and VASOGRADE-Red categories with DCI-related infarction were 7.7, 61.5, and 30.8%, respectively. After a multivariable analysis including age, sex, aneurysm location, and the VASOGRADE classification as variables, both VASOGRADE-Yellow and VASOGRADE-Red were independently associated with DCI-related infarction (odds ratio [OR] 7.69, 95% confidence interval [CI] 2.13-27.8, and OR 8.07, 95% CI 2.03-32.11, respectively) and unfavorable outcome (OR 4.16, 95% CI 1.33-13.03, and OR 25.57, 95% CI 4.45-147.1, respectively). The VASOGRADE discrimination performance for DCI-related infarction (area under the receiver operating characteristic curve) was 0.67 ± 0.04 (95% CI 0.58-0.75; p = 0.001). VASOGRADE-Red had 97.5% specificity for predicting an unfavorable mRs score at discharge (95% CI 92.8-99.5%). Conversely, VASOGRADE-Green had an excellent specificity for predicting favorable outcome at discharge (mRs score 0-2, 95% CI 82.6-95.5%).
CONCLUSIONS: In conclusion, in a multiethnic cohort of patients with aSAH, VASOGRADE-Green predicted the absence of DCI and good clinical outcome at discharge with very high specificity, and patients in this category might be selected for early intensive care unit (ICU) discharge, minimizing costs and medical complications associated with prolonged hospital stay. On the other hand, patients categorized as VASOGRADE-Yellow and VASOGRADE-Red were at the highest risk for DCI. They should, therefore, be selected as a priority for care in high-volume aSAH centers, being aggressively monitored for DCI at the ICU. Such stratification methods are crucial, especially in countries with low financial resources and high health care services demand.
参考来源
- Oliveira Souza NV, Rouanet C, Solla DJF, et al. The Role of VASOGRADE as a Simple Grading Scale to Predict Delayed Cerebral Ischemia and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2022. PMID: 36002635. doi:10.1007/s12028-022-01577-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。